the fact that TIMPB does not get a look in suggests to me there is something strange going on. Any serious investor would be buying TIMPB over TIM, even noting illiquidity.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025